EMETROL CHEWABLES ORANGE- sodium citrate dihydrate tablet, chewable

Emetrol Chewables Orange by

Drug Labeling and Warnings

Emetrol Chewables Orange by is a Otc medication manufactured, distributed, or labeled by WellSpring Pharmaceutical Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredients

• Sodium citrate dihydrate USP 230 mg

Purpose

Upset stomach reliever/antacid

Uses

For the relief of nausea associated with upset/sour stomach, including that due to overindulgence in food and drink.

Warnings

Do not use if you have

• Hereditary Fructose Intolerance (HFI). This product contains fructose.

Ask a doctor before use if you 

• have diabetes because this product contains sugar
• are on a sodium-restricted diet

Ask a doctor or pharmacist before use if

• you are taking any other medications. This product may interact with certain prescription drugs.
  

When using this product,

• do not take more than 24 tablets in a 24-hour period.
  

Stop use and ask a doctor if

• nausea lasts more than two weeks or recurs frequently.

If pregnant or breast-feeding,

• ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away.

Keep out of reach of children

Directions

• Adults: 2-4 tablets.
• Children: Consult a doctor for appropriate dosage.
• Chew tablets completely. Do not swallow whole
• Dosage may be repeated after 15 minutes, not to exceed 24 tablets in a 24-hour period unless advised by a doctor.
• Read all package directions and warnings before use and use only as directed.
• These tablets are intended for use by normally healthy persons only.
• Persons under 18 years of age should use only as directed by a doctor.

Other information

• Each table contains: Sodium 60mg
• Store at room temperature
• Protect product from excessive heat, cold and moisture
• Note: This product is not intended as a substitute for a balanced nutritional diet or as an electrolyte replenishment.
• Do not use if printed seal under cap is broken or missing.

Inactive ingredients

dextrose, flavor, fructose, hydroxypropyl cellulose, magnesium stearate, maltodextrin, silica, sodium carboxymethylcellulose, sucralose.

Questions or Comments?

1-844-241-5454 or Emetrol.com 

Distributed By

WellSpring Pharmaceutical Corporation
Sarasota, FL 34243
(c) 2023 WellSpring Pharmaceutical Corporation

PACKAGE LABEL

# 1 Pharmacist Recommended

New

Non-Drowsy

Emetrol Chewable Rapid Nausea Relief

Treats the source of Nausea*

*Due to overindulgence in food and drink

Powerful, Soothing Relief

Orange Flavor

60 Chewable Tablets

Emetrol Chewable tablet Orange

Side Panels

Emetrol Chewables Rapid Nausea Relief

Non-Drowsy

Treats the source of Nausea*

Specially Formulated for Adults

Great-tasting Lemon Chewables

*Due to overindulgence in food and drink

Emetrol Chewables relieves stomach discomfort with: 

No Acetaminophen

No Aspirin

No Caffeine

INGREDIENTS AND APPEARANCE

EMETROL CHEWABLES ORANGE 
sodium citrate dihydrate tablet, chewable

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 65197-410
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL)	ANHYDROUS CITRIC ACID	230 mg

Inactive Ingredients
Ingredient Name	Strength
DEXTROSE (UNII: IY9XDZ35W2)
FRUCTOSE (UNII: 6YSS42VSEV)
HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM (UNII: K679OBS311)
SUCRALOSE (UNII: 96K6UQ3ZD4)

Product Characteristics
Color	white	Score	no score
Shape	ROUND	Size	16mm
Flavor	ORANGE	Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 65197-410-60	1 in 1 BOX	07/01/2023
1		60 in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		07/01/2023

Labeler - WellSpring Pharmaceutical Corporation (110999054)